Key Takeaways
- • CVC agreed to acquire a 40% minority stake in Fibrotex, a maker of multispectral camouflage, through its CVC Catalyst III fund, with the founding Blum family retaining a controlling 60% interest.
- • Israeli outlet Calcalist reported the transaction values the 40% stake at $350 million; CVC did not disclose financial terms in its own announcement.
- • Calcalist estimated Fibrotex generated $130 million to $150 million in revenue in 2025.
- • Fibrotex operates principal sites in Kentucky and Petah Tikva, Israel, and sells to customers in more than 20 countries, including the United States, Japan, Australia, New Zealand and several European nations.
- • The deal is subject to customary regulatory approvals and is expected to close in the first half of 2027; Jefferies advised the Blum family and Rothschild advised CVC.
Summary
CVC has agreed to acquire a minority stake in Fibrotex, a manufacturer of advanced multispectral camouflage designed to reduce the detectability of personnel, vehicles and critical assets. The investment is being made through the CVC Catalyst III fund and is structured as a partnership with the founding Blum family, which will retain majority ownership.
According to Israeli business outlet Calcalist, CVC is buying a 40% stake for $350 million, leaving the Blum family with a controlling 60% interest. Calcalist also estimated that Fibrotex generated $130 million to $150 million in revenue in 2025. CVC did not disclose financial terms in its own announcement, so the valuation figures rest on Calcalist's reporting.
Fibrotex has principal locations in Kentucky and Petah Tikva, Israel, and serves customers in more than 20 countries, including the United States, Japan, Australia, New Zealand and several European nations. CVC said demand for protective technologies is supported by long-term defense modernization and rising security requirements, and that CVC Catalyst will back the company's innovation and international expansion.
The transaction remains subject to customary regulatory approvals and is expected to close in the first half of 2027. Jefferies advised the Blum family, and Rothschild advised CVC. The publisher notes the deal adds to a steady flow of private capital into defense supply chains, and that a minority position alongside a founding family gives a sponsor exposure to a specialized, export-driven defense supplier without the control and governance questions that often complicate sector buyouts.
According to Israeli business outlet Calcalist, CVC is buying a 40% stake for $350 million, leaving the Blum family with a controlling 60% interest. Calcalist also estimated that Fibrotex generated $130 million to $150 million in revenue in 2025. CVC did not disclose financial terms in its own announcement, so the valuation figures rest on Calcalist's reporting.
Fibrotex has principal locations in Kentucky and Petah Tikva, Israel, and serves customers in more than 20 countries, including the United States, Japan, Australia, New Zealand and several European nations. CVC said demand for protective technologies is supported by long-term defense modernization and rising security requirements, and that CVC Catalyst will back the company's innovation and international expansion.
The transaction remains subject to customary regulatory approvals and is expected to close in the first half of 2027. Jefferies advised the Blum family, and Rothschild advised CVC. The publisher notes the deal adds to a steady flow of private capital into defense supply chains, and that a minority position alongside a founding family gives a sponsor exposure to a specialized, export-driven defense supplier without the control and governance questions that often complicate sector buyouts.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.